<- Go Home
PanGenex Corporation
As of April 8, 2008, PanGenex Corporation was acquired by Calgenex Corporation, in a reverse merger transaction. PanGenex Corp. develops and markets nutraceuticals and topical over the counter (OTC) drugs and personal care products. Its products include Calci-CLEAR, a program that helps cleanse bodies of calcium crystals; Omeganol, a supplement that combines the triglyceride-lowering properties of omega 3s with the cholesterol balancing activity of tocotrienols; and Dermallve, a lotion that relieves symptoms of chronic skin diseases. The company caters to nutraceutical and cardiovascular health industries. PanGenex is based in Tampa, Florida.
Market Cap
$30.7M
Volume
4.00
Cash and Equivalents
$13.5K
EBITDA
-$1.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$78.3K
Profit Margin
9.40%
52 Week High
$8.3K
52 Week Low
$0.12
Dividend
N/A
Price / Book Value
-562.25
Price / Earnings
-566.74
Price / Tangible Book Value
-562.25
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$1.5M
Return on Equity
121.66%
Return on Assets
-76.02
Cash and Short Term Investments
$13.5K
Debt
$1.9M
Equity
-$2.1M
Revenue
$832.7K
Unlevered FCF
-$696.0K
Sector
Pharmaceuticals
Category
N/A